View source for 20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .)

= NTSR1-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY =

'''Abstract''':
methods for treating or ameliorating cancer comprising administering to a mammal a ntsr-1 targeted radiopharmaceutical comprising a radionuclide chelated to a compound of formula i, and dna damage response inhibitors.

'''Inventor(s)''': [[:Category:John R. Forbes of Burlington  CA|John R. Forbes]], [[:Category:Saleemulla Mahammad of Ancaster  CA|Saleemulla Mahammad]]

'''CPC Classification''': [[:Category:CPC_A61K51/0497|A61K51/0497]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))


[[Category:Patent Applications]]
[[Category:Fusion Pharmaceuticals Inc.]]
[[Category:CPC_A61K51/0497]]
[[Category:John R. Forbes of Burlington  CA]]
[[Category:Saleemulla Mahammad of Ancaster  CA]]

[https://wikipatents.org/index.php?search=20250177581+rejection&title=Special%3ASearch&wprov=acrw1_-1 Search for rejections for patent application number 20250177581]


<!-- JSON-LD markup for search engines:
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .)","name":"20250177581. Ntsr1-targeted Rad (Fusion Pharmaceuticals .)","description":"Patent application abstract and classification for 20250177581 - Ntsr1-targeted Rad","datePublished":"2025-06-10","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250177581","name":"Ntsr1-targeted Rad","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Fusion Pharmaceuticals Inc."}]}}
-->